CALYPTE BIOMEDICAL CORP Operating Expenses
CALYPTE BIOMEDICAL CORP reported Operating Expenses of $1.19 million for the 12-month period ending 2012-12-31, per its 10-K filed 2014-06-24.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2014-06-24
- CALYPTE BIOMEDICAL CORP operating expenses for the quarter ending 2012-12-31 was $322.00K, a 5.92% increase year-over-year.
- CALYPTE BIOMEDICAL CORP operating expenses for the quarter ending 2012-09-30 was $266.00K, a 18.15% decline year-over-year.
- CALYPTE BIOMEDICAL CORP operating expenses for the quarter ending 2012-06-30 was $269.00K, a 36.10% decline year-over-year.
- CALYPTE BIOMEDICAL CORP operating expenses for the quarter ending 2012-03-31 was $329.00K, a 34.59% decline year-over-year.
- CALYPTE BIOMEDICAL CORP operating expenses for fiscal 2012 was $1.19M, a 23.65% decline from fiscal 2011.
- CALYPTE BIOMEDICAL CORP operating expenses for fiscal 2011 was $1.55M, a 0.71% increase from fiscal 2010.
- CALYPTE BIOMEDICAL CORP operating expenses for fiscal 2010 was $1.54M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2012-12-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | $588.00K derived: sum of 2 quarters · filed 2014-06-24 | $857.00K derived: sum of 3 quarters · filed 2014-06-24 | $1.19M 10-K · filed 2014-06-24 |
| 2012-09-30 | $266.00K 10-Q · filed 2012-12-31 | $535.00K derived: sum of 2 quarters · filed 2012-12-31 | $863.00K 10-Q · filed 2012-12-31 | $1.17M derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-06-30 | $269.00K 10-Q · filed 2012-08-14 | $597.00K 10-Q · filed 2012-08-14 | $902.00K derived: sum of 3 quarters · filed 2014-06-24 | $1.23M derived: sum of 4 quarters · filed 2014-06-24 |
| 2012-03-31 | $329.00K 10-Q · filed 2012-05-15 | $633.00K derived: sum of 2 quarters · filed 2014-06-24 | $958.00K derived: sum of 3 quarters · filed 2014-06-24 | $1.38M derived: sum of 4 quarters · filed 2014-06-24 |
| 2011-12-31 | $304.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-24 | $629.00K derived: sum of 2 quarters · filed 2014-06-24 | $1.05M derived: sum of 3 quarters · filed 2014-06-24 | $1.55M 10-K · filed 2014-06-24 |
| 2011-09-30 | $325.00K 10-Q · filed 2012-12-31 | $746.00K derived: sum of 2 quarters · filed 2012-12-31 | $1.25M 10-Q · filed 2012-12-31 | $1.70M derived: sum of 4 quarters · filed 2012-12-31 |
| 2011-06-30 | $421.00K 10-Q · filed 2012-08-14 | $923.00K 10-Q · filed 2012-08-14 | $1.38M derived: sum of 3 quarters · filed 2012-08-14 | $1.77M derived: sum of 4 quarters · filed 2012-08-14 |
| 2011-03-31 | $503.00K 10-Q · filed 2012-05-15 | $954.00K derived: sum of 2 quarters · filed 2012-05-15 | $1.35M derived: sum of 3 quarters · filed 2012-05-15 | $1.64M derived: sum of 4 quarters · filed 2012-05-15 |
| 2010-12-31 | $451.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-22 | $850.00K derived: sum of 2 quarters · filed 2012-03-22 | $1.14M derived: sum of 3 quarters · filed 2012-03-22 | $1.54M 10-K · filed 2012-03-22 |
| 2010-09-30 | $399.00K 10-Q · filed 2012-01-27 | $685.00K derived: sum of 2 quarters · filed 2012-01-27 | $1.09M 10-Q · filed 2012-01-27 | |
| 2010-06-30 | $286.00K 10-Q/A · filed 2011-11-30 | $690.00K 10-Q/A · filed 2011-11-30 |